RxDoctor Payments Data

James Anderson, MD

Otolaryngology · Montgomery, ALNPI 1376634964

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Aerin Medical Inc. at 43.5% of the total. Reporting peaked in 2020 at $1,773 and has fallen 58.0% since, to $744 in 2025.

$6,260in general payments, 2019–2025

Across 67 payments — averaging $93.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$3K
  • Medtronic$1K
  • Inspire Medical Systems, Inc.$567
  • Stryker$524
  • Intersect ENT, Inc.$409
  • Regeneron Healthcare Solutions, Inc.$316
  • plus $598 from 9 others

What the payments were for

  • Consulting fees$80613%
  • Travel & lodging$2,22235%
  • Food & beverage$3,14250%
  • Education$901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,260 in reported general payments places this provider in the 85th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$110,236
Medicare patients
263
Services billed
2,200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine136$5,571
Azelastine Hcl81$2,914
Levocetirizine Dihydrochloride207$2,803
Montelukast Sodium135$2,028
Fluticasone Propionate126$1,961
Fluocinolone Acetonide Oil21$1,480
Omeprazole34$615
Ipratropium Bromide22$548
Ofloxacin13$467
Doxycycline Hyclate24$428
Prednisone41$406
Mupirocin16$128
Cephalexin17$56

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →